Back
Omnicom Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
51
OMC
Omnicom Group
Last Price:
$79.56
Seasonality Move:
4.69%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
$98.65
Seasonality Move:
6.73%
Buy
51
Omnicom Group (OMC)
is a Buy
Is Omnicom Group a Buy, Sell or Hold?
-
The current Omnicom Group [OMC] share price is $80.01. The Score for OMC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
OMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OMC Stock Price Chart
What is Omnicom Group's stock price today?
-
The Omnicom Group share price today is $80.01Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OMC is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $99.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
OMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 38.74 | Sell |
Chaikin Money Flow: | -2864353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.32 - 84.84) | Sell |
Bollinger Bands (100): | (83.36 - 100.98) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 37.2 | Sell |
Chaikin Money Flow: | -420668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.16 - 112.22) | Sell |
Bollinger Bands (100): | (109.63 - 127.19) | Sell |
OMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.08 | Sell |
20-day SMA: | 82.47 | Sell |
50-day SMA: | 84.46 | Sell |
200-day SMA: | 93.68 | Sell |
8-day EMA: | 82.16 | Sell |
20-day EMA: | 82.88 | Sell |
50-day EMA: | 85.56 | Sell |
200-day EMA: | 91.2 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.49 | Sell |
20-day SMA: | 106.07 | Sell |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 126.52 | Sell |
8-day EMA: | 103.1 | Sell |
20-day EMA: | 106.21 | Sell |
50-day EMA: | 111.8 | Sell |
200-day EMA: | 120.79 | Sell |
Omnicom Group Earnings Growth & OMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.42 per share, an increase this year of $0.41 per share, and an increase next year of $0.79 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Omnicom Group Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |